2402 ch19 sp09

Upload: teena-real

Post on 05-Apr-2018

244 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/2/2019 2402 ch19 sp09

    1/55

    1

    Chapter 19

    Cardiovascular System: The Blood

    Hematology

    Cells immersed in body fluids: Blood

    - Plasma

    - Formed elements (cells)

    Interstitial fluid

  • 8/2/2019 2402 ch19 sp09

    2/55

    2

    Functions of Blood

    Transportation

    Regulation

    pH body temp H2O content of cells BP

    Protection Blood loss Immunity

    http://encarta.msn.com/media_461557603_761578429_-1_1/Lymphocyte.html

  • 8/2/2019 2402 ch19 sp09

    3/55

    3

    Physical Characteristics of Blood

    Avg volume

    Consistency

    Color

    Temperature pH ~7.4

    http://www.phototakeusa.com/results.asp?txtkeys=Dennis+Kunkel

    http://www.phototakeusa.com/results.asp?image=ELBYSYR069239-01&wwwflag=&imagepos=7http://www.phototakeusa.com/results.asp?image=ELBYSYR069239-01&wwwflag=&imagepos=7
  • 8/2/2019 2402 ch19 sp09

    4/55

    4

    Blood SamplingPhlebotomy

    Venipuncture (mostcommon)

    Arterial stick

  • 8/2/2019 2402 ch19 sp09

    5/55

    5

    Blood SamplingPhlebotomy

    Finger or heel stick

    Capillary sample

  • 8/2/2019 2402 ch19 sp09

    6/55

    6

    Components of Blood: Plasma

    >90% water ~7% proteins: albumin, fibrinogen, globulins(immunoglobulins)

    ~2% other solutes: electrolytes, nutrients, gases,hormones, wastes

    http://encarta.msn.com/media_461557603_761578429_-1_1/Lymphocy

  • 8/2/2019 2402 ch19 sp09

    7/557

    Components ofBlood:Formed Elements

    RBC (erythrocyte)

    WBC (leukocyte)

    Granular leukocytes

    - neutrophil, eosinophil,basophil

    Agranular leukocytes

    - lymphocyte = T, B &NK cell, monocyte

    Platelet(thrombocyte)

    megakaryocyte

  • 8/2/2019 2402 ch19 sp09

    8/558

    Hematopoiesis (Hemopoiesis)

    Embryo

    Fetus

    Adult

  • 8/2/2019 2402 ch19 sp09

    9/559

    Stages of Hematopoiesis

    Pluripotenthematopoietic stemcell

    Myeloid stem cells Progenitor cells (CFU)

    Erythroblast reticulocyte RBC

    Megakaryocyte thrombocyte

    Granulocytes (PMN,basophil, eosinophil)

    Monocytemacrophage

    Dendritic cell

    Lymphoid stem cells T, B & NK cells

  • 8/2/2019 2402 ch19 sp09

    10/5510

    Hemopoietic Growth Factors

    Regulatedifferentiation &proliferation

    Erythropoietin (EPO)

    Thrombopoietin(TPO)

    Cytokines

    - colony-stimulatingfactor (CSF)

    - interleukin (IL)

    Recombinant DNAadvances

    Growth factor

    production

  • 8/2/2019 2402 ch19 sp09

    11/5511

    Red Blood Cells or Erythrocytes

    Biconcave disk Increases surface area:volume ratio

    Spectrin flexible protein

    Anucleate amitotic

  • 8/2/2019 2402 ch19 sp09

    12/5512

    Hemoglobin: Structure & Fxn

    Globin protein consists of 4 polypeptides (2a2b) 1 heme attached to each polypeptide heme contains iron

    binds 1 oxygen

    Oxyhemoglobin

    Deoxyhemoglobin

    Carbaminohemoglobin

    Myoglobin

  • 8/2/2019 2402 ch19 sp09

    13/5513

    HgB: Blood Pressure Regulation?

    HgB helps regulate nitric oxide (NO)

    When released NO induces vasodilation

    NO released from endothelial cells

  • 8/2/2019 2402 ch19 sp09

    14/5514

    Clinical Application: Abnormal HgB

    Thalassemia absent orfaulty globin chain in HgB

    Sx Tx

    http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom?picture=/websites/emedicine/radio/images/Large/201B.JPG&template=izoom2http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom?picture=/websites/emedicine/radio/images/Large/245I.JPG&template=izoom2
  • 8/2/2019 2402 ch19 sp09

    15/5515

    Clinical Application: Abnormal HgB

    Sickle-cell anemia Defective HgB gene (HbS)

    RBCs become sickle-shapedin low oxygen situations

    Cause anemia, ischemia &infarctionhttp://www.nlm.nih.gov/medlineplus/ency/imagepages/1223.htm

  • 8/2/2019 2402 ch19 sp09

    16/55

  • 8/2/2019 2402 ch19 sp09

    17/5517

    Erythropoiesis: Production of RBC

    Requires protein, lipids, CHO, iron, vB12, folicacid

    Three phases in developmental pathway

    Reticulocyte Erythrocyte

    - Diagnostic test

    Copyright 2004 Pearson Education, Inc., publishing as Benjamin Cummings

  • 8/2/2019 2402 ch19 sp09

    18/5518

    Total Erythrocytes (RBC)

    Circulatingerythrocytes

    # remains constant

    Normal RBC count- male 5.4 million/drop

    - female 4.8million/drop

    Reticulocytes Should be ~1% ofcirculating RBCs

    http://www.nlm.nih.gov/medlineplus/ency/imagepages/1491.htm

  • 8/2/2019 2402 ch19 sp09

    19/5519

    Hematocrit

    % blood occupied by RBC

    female normal range - 38 - 46%

    male normal range - 40 - 54%

    http://scienceu.fsu.edu/content/virtuallab/hematology/docs/hematocrit.html

  • 8/2/2019 2402 ch19 sp09

    20/5520

    Erythropoietin Mechanism

    Reduces O2levels in blood

    Erythropoietinstimulates redbone marrowEnhancederythropoiesis

    increases RBC

    count

    Normal blood oxygen levels Stimulus: Hypoxia due todecreased RBC count,decreased availability of O2to blood, or increased

    tissue demands for O2

    Start

    Kidney (and liver to asmaller extent) releaseserythropoietin

    IncreasesO2-carryingability of blood

  • 8/2/2019 2402 ch19 sp09

    21/5521

    Erythrocyte Disorders

    Polycythemia

    Blood doping Induced polycythemia

    recEPO or injectingpreviously stored RBCsbefore an athletic event

    - more cells available todeliver oxygen to tissues

    Dangerous- increases blood viscosity- forces heart to work

    harder

    - banned by Olympiccommittee

  • 8/2/2019 2402 ch19 sp09

    22/55

    22

    Anemia: Low O2 -carrying capacity

    General signs/Sx

    Types of anemia:

    Hemorrhagic anemia

    Hemolytic anemia

    Aplastic anemia

    Iron-deficiency anemia

    Pernicious anemia

    Fig 1. Normal bone marrow. 30-70% of

    marrow space consists of hematopoeiticcells w/ remainder being fat.

    Fig 2. Patient's bone marrowbiopsy w/ almost noidentifiable hematopoeisis.

  • 8/2/2019 2402 ch19 sp09

    23/55

    23

    White Blood Cells/ Leukocytes

    Complete blood cells

    Far less numerous thanRBCs

    Usually live a few days

    Except for lymphocytes live for months or

    years

    Leukocytosis

    Leukopenia

  • 8/2/2019 2402 ch19 sp09

    24/55

    24

    Leukocyte Functions:

    Inflammation & fightinfection

    Emigration

    Chemotaxis Diapedesis

    - Adhesion molecules(Selectins & integrins)

  • 8/2/2019 2402 ch19 sp09

    25/55

    25

    Classification of Leukocytes

    Granulocytes

    neutrophils, eosinophils, basophils,dendritic cells

    Agranulocytes monocytes (mf) or lymphocytes

    http://encarta.msn.com/media_461557603_761578429_-1_1/Lymphocyte.html

  • 8/2/2019 2402 ch19 sp09

    26/55

    26

    Neutrophils: Polymorphonuclear leukocytes

    Aka: PMN, Segs,Polys

    60-70% of circulatingWBCs

    Multi-lobed nuclei

    Granules = peroxidases,hydrolytic enz &defensins

    Band (shift)

    Functions

    targetbacteria Lysozymes Defensin proteins Strong oxidants Phagocytosis

    http://cal.vet.upenn.edu/histo/mammalblood/felbandneutbas.htm

    http://www.physioweb.org/blood_cells.html

  • 8/2/2019 2402 ch19 sp09

    27/55

    27

    Eosinophils (Granulocyte)

    ~1-4% circulating WBC

    Nucleus w/ 2-3 lobes

    Large, uniform-sized

    granules stain orange-

    red w/ acidic dyes

    Functions

    Release histaminase

    Phagocytize Ab-Agcomplexes

    Attack parasitic worms

    http://greenfield.fortunecity.com/rattler/46/blood.htm

    http://www.physioweb.org/blood_cells.html

  • 8/2/2019 2402 ch19 sp09

    28/55

    28

    Basophils (Granulocyte)

    < 1% of circulating WBC Large, dark purple, variable-

    sized granules

    Histamine

    Irregular, s-shaped, bilobednuclei

    Functions Leave capillaries & enter CT

    Release heparin, histamine &serotonin

    Intensify the inflammatory &allergy rxn

    - Involved with hypersensitivity rxns

  • 8/2/2019 2402 ch19 sp09

    29/55

    29

    Identify these cells:

    Basophil

    PMN

    Eosinophil

    RBC

    http://www.nursing.ucla.edu/Userpages/mwoo/cbc/_vti_bin/shtml.exe/smear.htm/map
  • 8/2/2019 2402 ch19 sp09

    30/55

    30

    Monocyte (Agranulocyte)

    3-8% of circulating WBCs

    Physical features

    U or kidney shaped nucleus

    Migratory

    Differentiate into macrophage (mf)

    - Fixed mf

    - Free (wandering) mf

    Phagocytes

    Antigen presenting cell (APC) viaMHC (major histocompatibilitycomplex)

    http://www.physioweb.org/blood_cells.html

  • 8/2/2019 2402 ch19 sp09

    31/55

    31

    Lymphocyte (Agranulocyte)

    General features ~25% of circulating

    WBCs

    Dark, oval to roundnucleus

    Types of lymphocytes NK cells (Innate)

    - Viral infected & tumorcells

    B cells (plasma)

    - Make antibody toantigens

    T cells- virus, fungi, cancer,

    some bacteria,transplants

    http://greenfield.fortunecity.com/rattler/46/blood.htm

    http://www.phototakeusa.com/results.asp?txtkeys=Dennis+Kunkel

    http://www.phototakeusa.com/results.asp?image=CFBLMIS100007-01&wwwflag=&imagepos=4http://www.phototakeusa.com/results.asp?image=CFBLMIS100007-01&wwwflag=&imagepos=4
  • 8/2/2019 2402 ch19 sp09

    32/55

    32

    Clinical Application: Leukemia

    Acute leukemia

    uncontrolledproduction ofimmature leukocytes

    Chronic leukemia

    accumulation of

    mature WBC inbloodstream becausethey do not die

  • 8/2/2019 2402 ch19 sp09

    33/55

    33

    Bone Marrow Transplant

    Procedure donor match (MHC)

    destroy sick bone marrow

    IV transfer of healthy bone

    marrow Risky business!

    Tx used for leukemia,sickle-cell, breast, ovarianor testicular cancer,

    lymphoma or aplasticanemia

    - Regimen-related toxicities

    - Infection

    - Graft versus host

    http://en.wikipedia.org/wiki/Image:Bone_marrow_biopsy.jpg
  • 8/2/2019 2402 ch19 sp09

    34/55

    34

    Another option?

    Cord blood transplant

    More Tolerant Matching

    More Quickly Available

    Less Graft-Versus-HostDisease

    Stem cells taken from

    umbilical cord & frozen -painless

    http://en.wikipedia.org/wiki/Image:Umbilicalcord.jpg
  • 8/2/2019 2402 ch19 sp09

    35/55

    35

    Platelet (Thrombocyte) Anatomy

    Cell fragment (anucleate) Formed in bone marrow Myeloid stem cell

    megakaryoblastmegakaryocyte fragments = platelets

    Thrombopoietin

    Short life span Old cells removed by fixed mf in

    liver & spleen

    Function in hemostasis Blood clotting (plug)

    http://en.wikipedia.org/wiki/Image:SEM_blood_cells.jpg
  • 8/2/2019 2402 ch19 sp09

    36/55

    36

    Total platelet count

    Normal count 150-400K platelets

    in each cc blood

    Thrombocytopenia

    Purpuric spots

    - petechiae

    - ecchymoses

    Thrombocythemia(Thrombocytosis)

    http://www.emedicine.com/med/topic987.htm

    http://www.healthsystem.virginia.edu/internet/hematology/hessidb/Platelet-Disorders.c

  • 8/2/2019 2402 ch19 sp09

    37/55

    37

    Hemostasis

    Quick stoppage of bleedingin localized area

    Prevents hemorrhage

    Rapid sequence of events:

    1. Vascular spasm

    (Vasoconstriction)

    2. Platelet plug formation

    (Primary hemostasis)

    3. Coagulation (Secondary

    hemostasis)

    Red blood cell

    Red blood cell

    Red blood cell

  • 8/2/2019 2402 ch19 sp09

    38/55

    38

    1

    Platelet

    Collagen fibersand damaged

    endothelium

    Platelet adhesion11

    2

    Platelet

    Collagen fibersand damaged

    endothelium

    Liberated ADP,serotonin, andthromboxane A2

    Platelet adhesion1

    Platelet release reaction2

    1

    2

    3

    Platelet

    Collagen fibersand damaged

    endothelium

    Liberated ADP,serotonin, andthromboxane A2

    Platelet plug

    Platelet adhesion1

    Platelet release reaction2

    Platelet aggregation3

    PlateletPlugFormation

    (a) Extrinsic pathway (b) Intrinsic pathway

    (a) Extrinsic pathway (b) Intrinsic pathway

    (a) Extrinsic pathway (b) Intrinsic pathway

  • 8/2/2019 2402 ch19 sp09

    39/55

    39

    Stages of Clotting:

    Clot = Fibrin + trapped RBC Clotting factors

    Involves three stages:

    1. Formation of prothrombinase2. Convert prothrombin thrombin

    3. Convert fibrinogen fibrin

    Two Pathways:

    Contact Activation pathway(formerly Intrinsic Pathway)

    Tissue Factor pathway (formerlyExtrinsic pathway)

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    (a) Extrinsic pathway (b) Intrinsic pathway

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+V

    1

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    (a) Extrinsic pathway (b) Intrinsic pathway

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+

    Prothrombin(II)

    Ca2+

    THROMBIN

    (c) Commonpathway

    V

    1

    2

    +

    +

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    (a) Extrinsic pathway (b) Intrinsic pathway

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+

    Prothrombin(II)

    Ca2+

    THROMBIN

    Ca2+

    Loose fibrinthreads

    STRENGTHENEDFIBRIN THREADS

    Activated XIII

    Fibrinogen(I)

    XIII

    (c) Commonpathway

    V

    1

    2

    3

    +

    +

    Extrinsic Pathway

  • 8/2/2019 2402 ch19 sp09

    40/55

    40

    Extrinsic Pathway(Tissue Factor Pathway)

    Formation of

    prothrombinase

    Damaged tissue leaks

    tissue factor(thromboplastin)

    Add in Ca2+ + Factor V/X

    Produce prothrombinase

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    (a) Extrinsic pathway (b) Intrinsic pathway

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+V

    1

    Intrinsic Pathway

  • 8/2/2019 2402 ch19 sp09

    41/55

    41

    Intrinsic Pathway(Contact Activation)

    Activation (endothelium

    damaged)

    Platelets bind collagen

    Activated platelets release

    phospholipids

    Ca+2 + factors XII

    activation of factors X & V prothrombinase

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    (a) Extrinsic pathway (b) Intrinsic pathway

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+V

    1

    (a) Extrinsic pathway (b) Intrinsic pathway

    (a) Extrinsic pathway (b) Intrinsic pathway

  • 8/2/2019 2402 ch19 sp09

    42/55

    42

    Common Pathway

    Prothrombinase + Ca+2 Converts prothrombin

    thrombin

    Thrombin + Ca+2 + XIIIaconverts fibrinogen toinsoluble fibrin

    Positive feedbackmechanism

    Accelerates formation ofprothrombinase

    Activates platelets torelease phospholipids

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    y ( ) p y

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+V

    1

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    y ( ) p y

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+

    Prothrombin(II)

    Ca2+

    THROMBIN

    (c) Commonpathway

    V

    1

    2

    +

    +

    (a) Extrinsic pathway (b) Intrinsic pathway

  • 8/2/2019 2402 ch19 sp09

    43/55

    43

    Blood Clotting

    Serum blood plasma

    w/o clottingproteins

    Clotting

    series ofchemical rxns formation offibrin threads

    Clotting factors Ca+2, inactive

    enzymes, &variousmoleculesassociated w/platelets orreleased bydamaged

    tissues

    Tissue trauma

    Tissuefactor(TF)

    Blood trauma

    Damagedendothelial cellsexpose collagenfibers

    Activated XII

    Ca2+

    Damagedplatelets

    Ca2+

    Plateletphospholipids

    Activated X

    Activatedplatelets

    Activated X

    PROTHROMBINASECa2+

    V

    Ca2+

    Prothrombin(II)

    Ca2+

    THROMBIN

    Ca2+

    Loose fibrinthreads

    STRENGTHENEDFIBRIN THREADS

    Activated XIII

    Fibrinogen(I)

    XIII

    (c) Commonpathway

    V

    1

    2

    3

    +

    +

  • 8/2/2019 2402 ch19 sp09

    44/55

    44

    Clot retraction Fibrinolysis

    Inactive plasminogen

    plasmin Activation requires factor XI, XII & thrombin Plasmin digests fibrin threads

  • 8/2/2019 2402 ch19 sp09

    45/55

    45

    Intravascular Clotting

    Thrombosis (thrombus) Blockage of vessel ischemia &

    necrosis

    Embolus http://www-medlib.med.utah.edu/WebPath/ATHH

  • 8/2/2019 2402 ch19 sp09

    46/55

    46

    Anticoagulants

    Oral anticoagulantsantagonize effects of Vit K

    - Warfarin (Coumadin)

    Heparin blocks thrombin

    formation- In vivo & in vitro

    Low dose aspirin (anti-prostaglandin)

    - Blocks synthesis ofthromboxane A2- Inhibits vasoconstriction &

    platelet aggregation

    - 75 or 81mg Baby aspirin

  • 8/2/2019 2402 ch19 sp09

    47/55

    47

    Thrombolytic agents

    Thrombolyticagents

    Dissolve clots

    Common drugs

    tPA tissue

    plasminogenactivator

    streptokinase

  • 8/2/2019 2402 ch19 sp09

    48/55

    48

    Clinical Application: Hemophilia

    Inherited deficiencyof clotting factors

    bleedingspontaneously orafter minor trauma

    Treatment

    Transfusions Clotting factors

  • 8/2/2019 2402 ch19 sp09

    49/55

    49

    Blood Groups and Blood Types

    Geneticallydetermined

    Categorized intoblood groups based

    on presence/absence of antigens

    Major blood groups =ABO & Rh groups

    Other blood groupsinclude Lewis, Kell,Kidd & Duffysystems

  • 8/2/2019 2402 ch19 sp09

    50/55

    50

    RH blood groups

    Discovered inRhesus monkeyblood

    Rh+

    vs Rh-

    Normal plasmacontains no anti-RhAb

    Transfusion rxnupon 2nd exposure hemolysis ofRBCs

    http://www.biologymad.com/master.html?http://www.biologymad.com/Immunology/Immunology.htm

  • 8/2/2019 2402 ch19 sp09

    51/55

    51

    ABO Blood System

    Plasma containsisoantibodies

    (agglutinins) to

    A, B or Rh Ag not

    found in yourblood

    Transfusion

    reactions http://www.biologymad.com/master.html?http://www.biologymad.com/Immunology/Immunology.htm

  • 8/2/2019 2402 ch19 sp09

    52/55

    52

    Transfusion & Transfusion Reactions

    Transfusion

    Incompatible bloodtransfusions

    Incompatibilitybetween donor &recipient

    Causes:

    - Agglutinationi. Ag-Ab complexes

    - Donated RBCs lysis

    - Renal failure

    http://www.nobel.se/medicine/educational/landsteiner/readmore.html

    http://www.kumc.edu/instruction/medicine/pathology/ed/ch_20a/c20a_s45.jpg
  • 8/2/2019 2402 ch19 sp09

    53/55

    53

    Hemolytic Disease of Newborn

    Rh- mom &Rh+ fetus

    First

    pregnancy =sensitization

    Subsequent

    pregnancy =

    reaction

    RhoGAM

  • 8/2/2019 2402 ch19 sp09

    54/55

    54

    Typing and Cross-Matching Blood

    Blood typing

    Agglutination (Ab

    + Ag)

    Cross-matching

    Screening

  • 8/2/2019 2402 ch19 sp09

    55/55

    Universal Donors and Recipients